Tag: CBT > CBD FDA: Page 5

Adult-Use Legalization Bill

Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research

The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.

January 17, 2020

Top Stories

At the Starting Line

CTPharma worked for five years to launch an FDA-approved clinical trial in partnership with Yale School of Medicine. Now that the company has the go-ahead, the real work begins.

December 18, 2019

Finance

The Cannabis Industry’s 9 Biggest Moments of 2019

This year saw many milestones, from historic votes in Congress to states launching cannabis sales for the first time.

December 9, 2019

Legislation and Regulation

Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market

Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.

December 6, 2019

Finance

FDA Warns of CBD Use and Marketing, Companies Respond

The FDA recently published a consumer notice regarding CBD’s unknown health effects and sent warning letters to companies allegedly marketing products illegally. Some have responded.

December 4, 2019

Legislation and Regulation

FDA Warns 15 Companies for Illegally Selling CBD Products

The violations include marketing unapproved new human and animal drugs, selling the products as dietary supplements, and adding CBD to human and animal foods.

November 26, 2019

Interviews & Opinion

AmourCBD Secures FDA Registration to Earn Customer Trust

The company has registered its CBD topical cream with the FDA to differentiate itself in the crowded marketplace.

November 7, 2019

Legislation and Regulation

U.S. Hemp Authority Releases Guidance Procedures 2.0

The updated guidance is based on a collaborative industry effort, including more than 2,000 public comments.

November 5, 2019

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019

International

Dr. Mechoulam Does It Again

In an exciting mainstream media report, NBC news highlighted a groundbreaking new development from the lab of Dr. Raphael Mechoulam, the godfather of cannabis chemistry: cannabinoid acids.

September 27, 2019

Compliance

Hawaii Health Officials Pull CBD Products Following First Vaping-Related Lung Illness

The question of regulated and unregulated CBD products has vexed state and federal officials for at least the past year.

September 17, 2019

2018 Farm Bill Status

How Far Has CBD Come Since the Passage of the 2018 Farm Bill?

From the FDA’s first-ever hearing on CBD to major retail chains carrying infused products, here is a summary of how hemp and CBD have progressed since federal legalization.

August 8, 2019